AbbVie Expands Immunology Portfolio in the European Union with the European Commission Approval of SKYRIZI (risankizumab) for the Treatment of Adults with Active...
Southern Illinois
•
Nov 17, 2021
Latest Illinois stories tagged “AbbVie”.